| Preetha S Rosen, MD | |
|
623 S Main St Ste 1, Moscow, ID 83843-3042 | |
| (208) 882-2011 | |
| Not Available |
| Full Name | Preetha S Rosen |
|---|---|
| Gender | Female |
| Speciality | Sleep Medicine |
| Experience | 17 Years |
| Location | 623 S Main St Ste 1, Moscow, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487886099 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084S0012X | Psychiatry & Neurology - Sleep Medicine | M-16797 (Idaho) | Secondary |
| 207QS1201X | Family Medicine - Sleep Medicine | M-16797 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gritman Medical Center | Moscow, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gritman Medical Center Inc | 0941545784 | 18 |
News Archive
Injections with a new type of botulinum toxin appears to be well tolerated and may help to improve the appearance of moderate to severe forehead lines with no evidence of diminishing treatment response over 13 months, according to a report in the March/April issue of Archives of Facial Plastic Surgery.
Pfizer Inc. today announced randomized Phase 2 data that showed PD-0332991 (PD-991) in combination with letrozole significantly extended progression free survival (PFS) compared with letrozole alone in post-menopausal patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer.
People who use antipsychotic medication (such as clozapine or risperidone) to treat psychiatric illness are nearly half as likely to commit a violent crime compared to when they are not using such medication, according to new results published in The Lancet.
Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal of Parkinson's Disease, Tomasz Brudek, PhD, evaluates evidence for the association between inflammatory bowel disease (IBD) and PD and proposes directions for future research.
› Verified 7 days ago
| Entity Name | Gritman Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619988144 PECOS PAC ID: 8729070164 Enrollment ID: O20040402001021 |
News Archive
Injections with a new type of botulinum toxin appears to be well tolerated and may help to improve the appearance of moderate to severe forehead lines with no evidence of diminishing treatment response over 13 months, according to a report in the March/April issue of Archives of Facial Plastic Surgery.
Pfizer Inc. today announced randomized Phase 2 data that showed PD-0332991 (PD-991) in combination with letrozole significantly extended progression free survival (PFS) compared with letrozole alone in post-menopausal patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer.
People who use antipsychotic medication (such as clozapine or risperidone) to treat psychiatric illness are nearly half as likely to commit a violent crime compared to when they are not using such medication, according to new results published in The Lancet.
Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal of Parkinson's Disease, Tomasz Brudek, PhD, evaluates evidence for the association between inflammatory bowel disease (IBD) and PD and proposes directions for future research.
› Verified 7 days ago
| Entity Name | Gritman Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477004828 PECOS PAC ID: 4981984390 Enrollment ID: O20161130002249 |
News Archive
Injections with a new type of botulinum toxin appears to be well tolerated and may help to improve the appearance of moderate to severe forehead lines with no evidence of diminishing treatment response over 13 months, according to a report in the March/April issue of Archives of Facial Plastic Surgery.
Pfizer Inc. today announced randomized Phase 2 data that showed PD-0332991 (PD-991) in combination with letrozole significantly extended progression free survival (PFS) compared with letrozole alone in post-menopausal patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer.
People who use antipsychotic medication (such as clozapine or risperidone) to treat psychiatric illness are nearly half as likely to commit a violent crime compared to when they are not using such medication, according to new results published in The Lancet.
Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal of Parkinson's Disease, Tomasz Brudek, PhD, evaluates evidence for the association between inflammatory bowel disease (IBD) and PD and proposes directions for future research.
› Verified 7 days ago
| Entity Name | Gritman Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538634522 PECOS PAC ID: 0941545784 Enrollment ID: O20181221002296 |
News Archive
Injections with a new type of botulinum toxin appears to be well tolerated and may help to improve the appearance of moderate to severe forehead lines with no evidence of diminishing treatment response over 13 months, according to a report in the March/April issue of Archives of Facial Plastic Surgery.
Pfizer Inc. today announced randomized Phase 2 data that showed PD-0332991 (PD-991) in combination with letrozole significantly extended progression free survival (PFS) compared with letrozole alone in post-menopausal patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer.
People who use antipsychotic medication (such as clozapine or risperidone) to treat psychiatric illness are nearly half as likely to commit a violent crime compared to when they are not using such medication, according to new results published in The Lancet.
Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal of Parkinson's Disease, Tomasz Brudek, PhD, evaluates evidence for the association between inflammatory bowel disease (IBD) and PD and proposes directions for future research.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Preetha S Rosen, MD Po Box 8007, Moscow, ID 83843-0507 Ph: (208) 882-4511 | Preetha S Rosen, MD 623 S Main St Ste 1, Moscow, ID 83843-3042 Ph: (208) 882-2011 |
News Archive
Injections with a new type of botulinum toxin appears to be well tolerated and may help to improve the appearance of moderate to severe forehead lines with no evidence of diminishing treatment response over 13 months, according to a report in the March/April issue of Archives of Facial Plastic Surgery.
Pfizer Inc. today announced randomized Phase 2 data that showed PD-0332991 (PD-991) in combination with letrozole significantly extended progression free survival (PFS) compared with letrozole alone in post-menopausal patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer.
People who use antipsychotic medication (such as clozapine or risperidone) to treat psychiatric illness are nearly half as likely to commit a violent crime compared to when they are not using such medication, according to new results published in The Lancet.
Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal of Parkinson's Disease, Tomasz Brudek, PhD, evaluates evidence for the association between inflammatory bowel disease (IBD) and PD and proposes directions for future research.
› Verified 7 days ago
Glenn David Rych, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 623 S Main St, Moscow, ID 83843 Phone: 208-882-2011 Fax: 208-883-1853 | |
Patricia N. Marciano, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 623 S Main St, Moscow, ID 83843 Phone: 208-882-2011 Fax: 208-883-1853 | |
Dr. Matthew Rice, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 803 S Main St Ste 120, Moscow, ID 83843 Phone: 208-848-8300 Fax: 509-444-7806 | |
Dr. Jacques Maurice Bouchard, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 623 S Main St Ste 1, Moscow, ID 83843 Phone: 208-882-2011 | |
Christopher Michael Standley, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 S Main St, Moscow, ID 83843 Phone: 208-882-4511 | |
Helen Marie Shearer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 623 S Main St, Moscow, ID 83843 Phone: 208-882-2011 Fax: 208-883-1853 | |
Vicky M Lott, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 623 South Main Street, Moscow, ID 83843 Phone: 208-882-2011 Fax: 208-883-1853 |